April 13, 2026 12:17 PM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Cronos Group

Cannabis Full Analysis Latest 

Democrats Take Aim At “Big Cannabis” In Proposed CAOC Legislation

September 7, 2021 5:33 PMSeptember 7, 2021 2:58 PM Jay Lutz 0 Comments Auxly Cannabis, Canopy Growth, Cronos Group, Hexo Corp, Organigram Holdings, Tilray, US Cannabis

It appears that the federal legalization of cannabis in the United States might not be in the best interest of

Share
Tweet
Share
Reddit
Read more
Biotech Cannabis Latest 

Cronos Group, Ginkgo Bioworks Achieve Partnership Productivity Target For CBG Acid

August 23, 2021 10:38 AMAugust 23, 2021 10:03 AM ER Velasco 0 Comments Cronos Group, Ginkgo Bioworks

Cronos Group, Inc. (TSX: CRON) and Ginkgo Bioworks announced this morning that its partnership has achieved the productivity target for

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group: Canaccord Lowers Price Target To $7 Following Poor Results

August 12, 2021 2:07 PMAugust 12, 2021 12:19 PM Justin Young 0 Comments Analyst Estimate, Cronos Group

Last week, Cronos Group (TSX: CRON) reported its second quarter financial results. The company generated $15.62 million in net revenue,

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Posts Another Gross Loss For Q2, Replaces CFO

August 6, 2021 8:34 AMAugust 6, 2021 8:34 AM Jay Lutz 0 Comments Cronos Group

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported their second quarter financial results. Revenues improved over the first quarter

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group: Analysts Expect Another Quarterly Loss For Q2

August 4, 2021 3:50 PMAugust 3, 2021 10:22 PM Justin Young 0 Comments Analyst Estimate, Cronos Group

Cronos Group (TSX: CRON) announced that they will be reporting their second quarter financials before market open on August 6.

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos: Raymond James Reiterates Price Target After PharmaCann Investment

June 15, 2021 5:50 PMJune 15, 2021 1:50 PM Justin Young 0 Comments Analyst Estimate, Cronos Group, PharmaCann

Yesterday, Cronos Group (TSX: CRON) showed once again that the demand for U.S cannabis assets is high with their strategic

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Announces 10.5% Investment Into US Operator PharmaCann

June 14, 2021 8:06 AMJune 14, 2021 8:06 AM Jay Lutz 0 Comments Cronos Group, PharmaCann

It appears that rules pertaining to ownership of US cannabis operations are loosening at the TSX Exchange and US big

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Begins Commercial Production Of CBG Under Modified Ginkgo Agreement

June 4, 2021 7:50 AMJune 4, 2021 7:50 AM Jay Lutz 0 Comments Cronos Group, Ginkgo Bioworks

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning announced that it has amended its collaboration and licensing arrangement with that

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos: Raymond James Remains Bullish Despite Revenue Miss

May 11, 2021 5:47 PMMay 11, 2021 4:53 PM Justin Young 0 Comments Analyst Estimate, Cronos Group

Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its first-quarter financial results on Friday, May 7th. The company announced revenues of

Share
Tweet
Share
Reddit
Read more
Biotech Cannabis Latest SPACs 

Ginkgo Bioworks To Go Public Via SPAC Route With Soaring Eagle Acquisition Corp

May 11, 2021 10:30 AMMay 11, 2021 10:30 AM Jay Lutz 0 Comments Cronos Group, Ginkgo Bioworks, Soaring Eagle Acquisition Corp, SPACs

It appears that Cronos Group (TSX: CRON) (NASDAQ: CRON) might be losing its star player. Ginkgo Bioworks this morning announced

Share
Tweet
Share
Reddit
Read more
  • ← Previous
  • Next →

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • The Golden Triangle: British Columbia’s Exploration Hotbed
  • Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
  • Missouri Cannabis Sales Rake in $240 Million in New Tax Revenue Over Past Year
  • Jimmy Kimmel Threatens Aaron Rodgers With A Lawsuit After 'Epstein List' Comment
  • New Zealand's Prospects As A New Mining Frontier

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.